Literature DB >> 25901074

Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.

Deirdre A Lane1, Kathryn Wood2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25901074      PMCID： PMC4408611          DOI： 10.1161/CIRCULATIONAHA.114.012808

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  Hemorrhage Risk Profiles among Different Antithrombotic Regimens: Evidence from a Real-World Analysis of Postmarketing Surveillance Data.

Authors:  Xue Sun; Bi Ze; Ling-Jun Zhang; Yang-Zhong BaiMa; Wei Zuo; Bin Zhao; Luo-Bo GeSang
Journal:  Cardiovasc Drugs Ther       Date:  2020-11-23       Impact factor: 3.727

2.  Differences In Gastrointestinal Safety Profiles Among Novel Oral Anticoagulants: Evidence From A Network Meta-Analysis.

Authors:  Wen-Qin Guo; Xie-Hui Chen; Xiao-Yuan Tian; Lang Li
Journal:  Clin Epidemiol       Date:  2019-10-01       Impact factor: 4.790

3.  Does Warfarin or Rivaroxaban at Low Anticoagulation Intensity Provide a Survival Benefit to Asian Patients With Atrial Fibrillation?

Authors:  Dong Lin; Yequn Chen; Jian Yong; Shiwan Wu; Yan Zhou; Weiping Li; Xuerui Tan; Ruisheng Liu
Journal:  Front Cardiovasc Med       Date:  2021-11-25

Review 4.  Gastrointestinal Bleeding and Direct Oral Anticoagulants among Patients with Atrial Fibrillation: Risk, Prevention, Management, and Quality of Life.

Authors:  Paolo Zappulla; Valeria Calvi
Journal:  TH Open       Date:  2021-06-16

5.  Development and validation of a questionnaire to self-assess patient knowledge of direct oral anticoagulants (KODOA-test).

Authors:  Corina Metaxas; Valerie Albert; Matthias Stahl; Kurt E Hersberger; Isabelle Arnet
Journal:  Drug Healthc Patient Saf       Date:  2018-07-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.